Younger age in patients with metastatic colorectal cancer associates with poorer outcome

New data from an analysis of data in the large ARCAD databank identify patients with metastatic colorectal cancer under the age of 40 years as a high-risk population for treatment failure and poorer overall- and progression-free survival. The findings were presented during the Gastrointestinal Malignancies/Colorectal Cancer II Proffered Papers Session (Abstract E17-1484) at the European Cancer Congress. Read more here.